104 related articles for article (PubMed ID: 16799103)
1. Use of beta2 agonists in sport: are the present criteria right?
Naranjo Orellana J; Centeno Prada RA; Carranza Márquez MD
Br J Sports Med; 2006 Apr; 40(4):363-6; discussion 366. PubMed ID: 16556795
[TBL] [Abstract][Full Text] [Related]
2. Beyond bronchodilation: Illuminating the performance benefits of inhaled beta
Hostrup M; Jessen S
Scand J Med Sci Sports; 2024 Jan; 34(1):e14567. PubMed ID: 38268072
[TBL] [Abstract][Full Text] [Related]
3. The World Anti-Doping Code: can you have asthma and still be an elite athlete?
Fitch K
Breathe (Sheff); 2016 Jun; 12(2):148-58. PubMed ID: 27408633
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist assessment to prevent inadvertent prohibited substance use among competitive strength athletes.
Smith-Morris AD; Lien K; Arnold BE
Can Pharm J (Ott); 2018; 151(6):372-376. PubMed ID: 30559911
[No Abstract] [Full Text] [Related]
5. β₂-Agonists and physical performance: a systematic review and meta-analysis of randomized controlled trials.
Pluim BM; de Hon O; Staal JB; Limpens J; Kuipers H; Overbeek SE; Zwinderman AH; Scholten RJ
Sports Med; 2011 Jan; 41(1):39-57. PubMed ID: 21142283
[TBL] [Abstract][Full Text] [Related]
6. Asthma in elite athletes.
Elers J; Pedersen L; Backer V
Expert Rev Respir Med; 2011 Jun; 5(3):343-51. PubMed ID: 21702657
[TBL] [Abstract][Full Text] [Related]
7. Beta2-Agonist Doping Control and Optical Isomer Challenges.
Jacobson GA; Fawcett JP
Sports Med; 2016 Dec; 46(12):1787-1795. PubMed ID: 27164986
[TBL] [Abstract][Full Text] [Related]
8. Inhaled salbutamol does not affect athletic performance in asthmatic and non-asthmatic cyclists.
Koch S; MacInnis MJ; Sporer BC; Rupert JL; Koehle MS
Br J Sports Med; 2015 Jan; 49(1):51-5. PubMed ID: 24100289
[TBL] [Abstract][Full Text] [Related]
9. Acute Effects of Single Versus Combined Inhaled β2-Agonists Salbutamol and Formoterol on Time Trial Performance, Lung Function, Metabolic and Endocrine Variables.
Bizjak DA; Nussbaumer D; Winkert K; Treff G; Takabajashi K; Mentz L; Schober F; Buhl JL; John L; Dreyhaupt J; Steeb L; Harps LC; Parr MK; Diel P; Zügel M; Steinacker JM
Sports Med Open; 2023 Aug; 9(1):79. PubMed ID: 37640958
[TBL] [Abstract][Full Text] [Related]
10. The ELSA trial: single versus combinatory effects of non-prohibited beta-2 agonists on skeletal muscle metabolism, cardio-pulmonary function and endurance performance-study protocol for a randomized 4-way balanced cross-over trial.
Zügel M; Bizjak DA; Nussbaumer D; Winkert K; Takabayashi K; Kirsten J; Washington M; Treff G; Dreyhaupt J; Steeb L; Diel P; Parr MK; Steinacker JM; Persch H
Trials; 2021 Dec; 22(1):903. PubMed ID: 34895300
[TBL] [Abstract][Full Text] [Related]
11. Salbutamol exhibits androgenic activity in vitro.
von Bueren AO; Ma R; Schlumpf M; Lichtensteiger W
Br J Sports Med; 2007 Dec; 41(12):874-8; discussion 878. PubMed ID: 17510230
[TBL] [Abstract][Full Text] [Related]
12. Inhaled beta2 agonists and performance in competitive athletes.
Kindermann W; Meyer T
Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
[TBL] [Abstract][Full Text] [Related]
13. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
Wolfarth B; Wuestenfeld JC; Kindermann W
Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
[TBL] [Abstract][Full Text] [Related]
14. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
Kindermann W
Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
[TBL] [Abstract][Full Text] [Related]
15. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical treatment of asthma symptoms in elite athletes - doping or therapy?
Backer V; Lund T; Pedersen L
Scand J Med Sci Sports; 2007 Dec; 17(6):615-22. PubMed ID: 18093034
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
